论文部分内容阅读
目的 探讨血E3检测对妊娠晚期胎儿—胎盘功能监测的临床价值。方法 按照试剂药盒说明书给出的方法测定 2 65 6例孕妇血清中E3的含量 ,并以 5ug/L作为临界值划分。结果 2 65 6例血清E3检测中有 10 3例 <5ug/L所占比例为 3 .88%,且对这 10 3例结果偏低的产检孕妇作血E3连续追踪测定 ,结合超声多普勒 ,B超以及其他辅助诊断 ,并且做产前、产后追踪。发现 10 3例首次结果偏低孕妇二次或两次以上连续检测血E3偏低有 5 9例。其中 7例确诊为胎儿宫内发育迟缓 ,3例胎儿宫内窘迫 ,1例死胎。结论 提示妊娠晚期血清E3测定特别是连续检测对胎儿—胎盘功能监测 ,辅助诊断及预后有较高价值
Objective To investigate the clinical value of serum E3 detection in the monitoring of fetal-placental function during the third trimester of pregnancy. Methods The content of E3 in serum of 2 656 pregnant women was determined according to the method given in the instructions of the reagent kit and divided by 5ug / L as the critical value. Results 2 656 cases of serum E3 detection of 103 cases <5ug / L accounted for 3.88%, and the results of these 103 poor results for pregnant women with E3 continuous tracing determination, combined with ultrasound Doppler , B ultrasound and other auxiliary diagnosis, and do prenatal and postnatal follow-up. Found 93 cases of low initial results for the first time in pregnant women more than twice or more continuous detection of blood E3 low 59 cases. Among them, 7 cases were diagnosed as intrauterine growth retardation, 3 cases of fetal distress and 1 case of stillbirth. The conclusions suggest that serum E3, especially continuous testing, in late trimester has high value for fetal-placental function monitoring, adjuvant diagnosis and prognosis